科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background: Many (artificial) bone substitute materials are currently available for use in orthopaedic trauma surgery. Objective data on their biological and biomechanical characteristics, which determine their clinical application, is mostly lacking. The aim of this study was to investigate structural and in vitro mechanical properties of nine bone substitute cements registered for use in orthopaedic trauma surgery in the Netherlands. Methods: Seven calcium phosphate cements (BoneSource (R), Calcibon (R), ChronOS (R), Eurobone (R), HydroSet (TM), Norian SRS (R), and Ostim (R)), one calcium sulphate cement (MIIG (R) X3), and one bioactive glass cement (Cortoss (R)) were tested. Structural characteristics were measured by micro-CT scanning. Compression strength and stiffness were determined following unconfined compression tests. Results: Each bone substitute had unique characteristics. Mean total porosity ranged from 53% (Ostim (R)) to 0.5% (Norian SRS (R)). Mean pore size exceeded 100 mu m only in Eurobone (R) and Cortoss (R) (162.2 +/- 107.1 mu m and 148.4 +/- 70.6 mu m, respectively). However, 230 mu m pores were found in Calcibon (R), Norian SRS (R), HydroSet (TM), and MIIG (R) X3. Connectivity density ranged from 27/cm(3) for HydroSet (TM) to 0.03/cm(3) for Calcibon (R). The ultimate compression strength was highest in Cortoss (R) (47.32 MPa) and lowest in Ostim (R) (0.24 MPa). Young's Modulus was highest in Calcibon (R) (790 MPa) and lowest in Ostim (R) (6 MPa). Conclusions: The bone substitutes tested display a wide range in structural properties and compression strength, indicating that they will be suitable for different clinical indications. The data outlined here will help surgeons to select the most suitable products currently available for specific clinical indications.
- 出版日期2011-2-2
